閱讀報導

實驗證實 高麗蔘讓骨骼密度增加32%


新聞來源:SCITECH EUROPA

高麗蔘協會日前發表高麗蔘對骨質疏鬆症患者骨骼健康有效的新證據

高麗蔘是指在韓國生產的人蔘。人蔘的學名是Panax ginseng,以希臘語“ Panax”命名,意思是能治療所有疾病;事實證明人蔘自古以來就是醫學的追捧者。韓國最近發布的研究顯示,高麗蔘已被證實可以改善免疫系統和疲勞,最新研究發現甚至可以改善骨骼健康。
 

2019年6月 韓國生物科學與生物技術研究院(KRIBB)和春北國立大學醫院(Chonbuk National University Hospital ) 證實了高麗蔘對骨骼健康的功效,該研究歷時3年,隨後進行了兩年隨訪。臨床應用研究是針對三組40歲以上且患有骨質流失的女性參與者進行。臨床應用研究對象共有90位參與者,每組30位參與者。對照組參與者接受安慰劑治療,而其他組則接受高麗蔘提取物(每天3g和每天1g)。

 

結果表明,試驗組骨鈣素水平是對照組的11.6倍;含3g高麗蔘提取物的測試組中鈣水平也高3倍。服用高麗蔘提取物前後骨關節炎評分的變化也很明顯,證明高麗蔘具有改善因骨質流失而引起的疼痛和僵硬的功效。

 

在動物試驗中,以高麗蔘提取物在小鼠施用8週。實驗結果還顯示,測試組的骨密度高32%。試驗組的鈣濃度和骨形成作用也較高。

 

韓國人參協會會長潘先生說:“因為這個有關高麗蔘對骨骼健康功效的新證據,讓我們對韓國高麗蔘感到更加有信心。我們希望繼續為高麗蔘的益處找到科學依據。”


新聞原文,出處:SCITECH EUROPA


The Korea Ginseng Association introduced new evidence of Korean Ginseng’s efficacy on bone health in those suffering from bone loss.

 

Korean Ginseng refers to ginsengs produced in Korea. Ginseng’s scientific name, Panax ginseng, is named after the Greek word ‘Panax’, meaning cure for all diseases; indeed, ginseng has been sought after medicine since the ancient times. It has been proven to improve immune system and fatigue previously, and now even for bone health, as seen in recent research released in Korea.

 

In June of 2019, Rural Development Administration, Korea Research Institute of Bioscience & Biotechnology (KRIBB) and Chonbuk National University Hospital confirmed the efficacy of Korean ginseng’s efficacy on bone health in a research conducted for 3 years and followed up for another two years. The clinical application study was performed with three groups of female participants over the age of 40 and who suffer from bone loss. There were a total of 90 participants, with 30 participants in each group. The participants in the control group were given placebo, while the other groups were given ginseng extracts (3g per day and 1g per day).

 

The results indicated that the level of osteocalcin was 11.6 times higher in the test group than the control group; the level of calcium was 3 times higher in the test group with 3g extracts as well. The change in Osteoarthritis rating before and after taking the extract was also significant, indicating ginseng’s efficacy on improving pain and rigidity due to bone loss.

 

In animal testing, ginseng extract (300mg per kg of mouse body mass) was administered for 8 weeks in Panax that were 112 weeks old. The result also indicated that bone density was 32% higher in the test group. The calcium concentration and bone formation effect were also higher in the test group.

 

The Korea Ginseng Association’s president Mr. Ban mentioned, “With this new evidence on ginseng’s efficacy on bone health, we have even more pride for our Korean Ginseng. We hope to continue to find scientifically based evidence for the ginseng’s benefits.”